Ticker >

Syschem (India) share price

Syschem (India) Ltd.

BSE: 531173 SECTOR: Pharmaceuticals & Drugs  11k   13   2

63.25
-0.31 (-0.49%)
BSE: 24 Apr 04:01 PM

Price Summary

Today's High

₹ 64.2

Today's Low

₹ 62

52 Week High

₹ 73.9

52 Week Low

₹ 33.36

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

252.13 Cr.

Enterprise Value

253.08 Cr.

No. of Shares

3.99 Cr.

P/E

73.87

P/B

4.41

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  14.35

CASH

0.66 Cr.

DEBT

1.61 Cr.

Promoter Holding

53.89 %

EPS (TTM)

₹  0.86

Sales Growth

92.47%

ROE

31.84 %

ROCE

38%

Profit Growth

364.36 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year92.47%
3 Year13.86%
5 Year11.29%

Profit Growth

1 Year364.36%
3 Year64.3%
5 Year67.99%

ROE%

1 Year31.84%
3 Year-20.16%
5 Year-14.01%

ROCE %

1 Year38%
3 Year-1.31%
5 Year-1.33%

Debt/Equity

0.072

Price to Cash Flow

-29.68

Interest Cover Ratio

147.097387173397

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 53.89 0
Dec 2023 53.89 0
Sep 2023 53.79 0
Jun 2023 53.82 0
Mar 2023 53.82 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 147.097387173397.
  • Company’s PEG ratio is 0.252067504219426.
  • The company has an efficient Cash Conversion Cycle of -12.9050082791425 days.
  • The company has a high promoter holding of 53.89%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 6.83860050157374.

 Limitations

  • The company has shown a poor revenue growth of 13.8634614246927% for the Past 3 years.
  • Company has a poor ROE of -20.1644256791932% over the past 3 years.
  • Company has a poor ROCE of -1.30928263973243% over the past 3 years
  • Company has negative cash flow from operations of -8.4949.
  • The company has a low EBITDA margin of 0.736996460587208% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 31.8113.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 34.62 56.91 50.29 43.68 51.51
Total Expenditure 31.78 54.39 47.84 41.83 50.44
Operating Profit 2.84 2.52 2.45 1.85 1.07
Other Income 0.01 0.06 0.01 0 0.01
Interest 0.06 -0.04 0.1 0.03 0.11
Depreciation 0.71 0.59 0.68 0.7 0.74
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.08 2.03 1.68 1.12 0.23
Tax 0 1.64 0 0 0
Profit After Tax 2.08 0.39 1.68 1.12 0.23
Adjusted EPS (Rs) 0.6 0.11 0.48 0.35 0.06

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 93.11 76.92 68.49 59 113.56
Total Expenditure 89.53 77.05 73.65 58.44 104.91
Operating Profit 3.58 -0.12 -5.16 0.57 8.65
Other Income 0.08 0.09 0.26 0.13 0.25
Interest 0.01 0.02 0.06 0.28 0.04
Depreciation 2.15 2.15 2.35 2.58 2.7
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.5 -2.2 -7.31 -2.17 6.15
Tax 0.75 -0.35 -1.75 -0.47 1.64
Net Profit 0.75 -1.85 -5.57 -1.71 4.51
Adjusted EPS (Rs.) 0.37 -0.91 -2.37 -0.67 1.3

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 18.79 18.79 21.54 23.29 31.89
Total Reserves -6.77 -8.78 -14.42 -16.35 -9.59
Borrowings 12.83 13.8 12.56 1.75 1.61
Other N/C liabilities -1.37 -1.72 13.12 21.64 23.53
Current liabilities 37.08 38.64 40.89 25.54 42.98
Total Liabilities 60.55 60.73 73.7 55.87 90.42
Assets
Net Block 26.94 27.55 29.71 31.54 30.65
Capital WIP 0.01 0.66 0.98 0 0.15
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.2 0.36 0.13 0.13 0.26
Other N/C Assets 0.98 1.05 0.74 0.65 0.79
Current Assets 32.41 31.11 42.14 23.55 58.57
Total Assets 60.55 60.73 73.7 55.87 90.42
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 1.5 -2.2 -7.31 -2.17 6.15
Adjustment 2.66 2.19 2.66 2.79 2.82
Changes in Assets & Liabilities -5.12 3.12 6.62 -0.01 -15.82
Tax Paid -0.75 0.35 1.75 0.47 -1.64
Operating Cash Flow -1.71 3.46 3.72 1.07 -8.49
Investing Cash Flow 1.83 -3.62 -3.77 -0.78 9.08
Financing Cash Flow -0.01 -0.02 -0.06 -0.28 -0.04
Net Cash Flow 0.11 -0.18 -0.11 0 0.54

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 53.82 53.82 53.79 53.89 53.89
bhavesh virendra shah 4.51 4.51 - 5.08 5.08
bimal virendra shah 4.51 4.51 4.51 5.08 5.08
dinesh jagdishchandra kho... - 5.49 5.49 7.00 7.00
mahesh j khokhani 6.66 6.66 6.66 7.27 7.27
mehul jagadishchandra kho... - 4.88 4.88 6.30 6.30
ranjan jain 10.91 10.91 10.91 8.73 8.73
ruchika jain 5.81 5.81 5.81 4.65 4.65
virendra popatlal shah 8.02 8.02 8.02 9.78 9.78
bhavesh virendra shah - - 4.51 - -
suninder veer singh 3.01 3.01 3.01 - -
gurcharan kaur 0.02 0.02 - - -
dinesh jagdish khokhani 5.49 - - - -
mehul jagdish khokhani 4.88 - - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 46.18 46.18 46.21 46.11 46.11
ashika global finance pri... - - 1.27 3.21 4.18
kamal gadalay 2.11 2.11 2.11 1.68 1.68
rajesh gupta - - - 1.01 1.04
suresh gadalay 2.04 2.04 1.97 1.54 1.44

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Syschem (India) informs about details of loss of certificate 18 Apr 2024, 3:13PM Syschem (India) informs about press release12 Mar 2024, 4:36PM Syschem India informs about update on petition26 Feb 2024, 5:30PM Syschem (India) - Quaterly Results9 Feb 2024, 1:33PM Syschem (India) - Quaterly Results9 Feb 2024, 1:33PM Syschem (India) submits board meeting intimation29 Jan 2024, 12:48PM Syschem (India) informs about disclosures 28 Dec 2023, 4:28PM Syschem (India) informs about trading window closure26 Dec 2023, 4:40PM Syschem India informs about disclosure22 Dec 2023, 10:48AM Syschem (India) informs about disclosure18 Dec 2023, 1:53PM Syschem (India) informs about disclosure6 Nov 2023, 5:04PM Syschem (India) informs about disclosure 6 Nov 2023, 4:57PM Syschem (India) informs about board meeting1 Nov 2023, 3:25PM Syschem (India) bags sales order worth Rs 24.50 lakh7 Sep 2023, 10:11AM Syschem (India) bags sales order worth Rs 28.02 lakh4 Sep 2023, 2:59PM Syschem (India) informs about updation on sales order received 21 Aug 2023, 5:03PM Syschem (India) informs about updates21 Aug 2023, 2:50PM Syschem (India) bags sales order worth Rs 83.23 lakh21 Aug 2023, 12:08PM Syschem (India) bags sales order worth around Rs 1.85 crore19 Aug 2023, 2:15PM Syschem (India) gets sales order worth Rs 3.06 crore19 Aug 2023, 10:52AM Syschem (India) receives sales order of around Rs 1.20 crore18 Aug 2023, 2:41PM Syschem (India) - Quaterly Results4 Aug 2023, 12:57PM Syschem (India) - Quaterly Results4 Aug 2023, 12:57PM Syschem (India) informs about outcome of board meeting7 Jun 2023, 2:45PM Syschem (India) - Quaterly Results15 May 2023, 2:21PM Syschem (India) - Quaterly Results15 May 2023, 2:21PM Syschem (India) - Quaterly Results15 May 2023, 2:21PM Syschem (India) informs about notice of postal ballot18 Mar 2023, 12:52PM Syschem (India) informs about resignation of director23 Jan 2023, 3:18PM Syschem (India) - Quaterly Results20 Jan 2023, 4:29PM Syschem (India) - Quaterly Results20 Jan 2023, 4:29PM Syschem (India) - Quaterly Results20 Jan 2023, 4:29PM Syschem (India) informs about board meeting 12 Jan 2023, 3:04PM Syschem (India) informs about disclosure 13 Dec 2022, 5:11PM Syschem (India) informs about postal ballot notice8 Dec 2022, 5:08PM Syschem (India) - Quaterly Results2 Nov 2022, 1:22PM Syschem (India) - Quaterly Results2 Nov 2022, 1:22PM Syschem (India) - Quaterly Results2 Nov 2022, 1:22PM Syschem (India) informs about disclosure15 Sep 2022, 12:48PM Syschem (India) informs about annual report25 Aug 2022, 4:33PM Syschem (India) informs about newspaper publication25 Aug 2022, 1:52PM Syschem (India) - Quaterly Results27 Jul 2022, 6:20PM Syschem (India) - Quaterly Results27 Jul 2022, 6:20PM Syschem (India) informs about declaration of voting results of EGM 18 Jun 2022, 4:42PM Syschem (India) informs about newspaper advertisements16 Mar 2022, 5:08PM Syschem (India) informs about trading window closure7 Mar 2022, 10:24AM Syschem (India) - Quaterly Results10 Feb 2022, 4:35PM Syschem (India) - Quaterly Results10 Feb 2022, 4:35PM Syschem India informs about press release5 Aug 2021, 3:10PM Syschem (India) informs about annual report annual report3 Aug 2021, 2:04PM

Syschem (India) Stock Price Analysis and Quick Research Report. Is Syschem (India) an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Syschem (India) and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Syschem (India) cash from the operating activity was Rs -8.4949 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Syschem (India) has a Debt to Equity ratio of 0.072 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Syschem (India) , the EPS growth was 293.069577080491 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Syschem (India) has OPM of 7.61480638695837 % which is a bad sign for profitability.
     
  • ROE: Syschem (India) have a healthy ROE of 31.8368757803847 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Syschem (India) is Rs 63.25. One can use valuation calculators of ticker to know if Syschem (India) share price is undervalued or overvalued.
Last Updated on:
Brief about Syschem (India)
X